TRAWS PHARMA INC
TRAW·68232V884·US·Common Stock·Healthcare - Biotechnology-Activist
TRAW (TRAWS PHARMA INC) is held by 20 institutional investors as of Q2 2026. Largest holders: ADAGE CAPITAL PARTNERS GP, L.L.C. ($615,609), VANGUARD CAPITAL MANAGEMENT LLC ($278,231), JANE STREET GROUP, LLC ($182,158). Net institutional sentiment: Mixed.
20
Holders
(1 Elite)
$1.5M
Total Value
63% (19)
Consensus
12 buying - 7 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 14, 2026 · Insiders Apr 28, 2026 · Activists Aug 14, 2026 · Congress none
ActivistSMSquadron Master Fund LP0.0%Aug 14, 2026
ActivistSISirenia Capital Management LP9.9%Aug 14, 2026
ActivistIKIkarian Capital, LLC9.5%Aug 14, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 23
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer